Brief: Isofol's Board Appoints Thomas Andersson As New CEO Of The Company
Feb 28 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* ISOFOL'S BOARD APPOINTS THOMAS ANDERSSON AS NEW CEO OF THE
COMPANY
* CURRENT CEO, ULF JUNGNELIUS, IS RESIGNING AND IS NOW BEING
DISMISSED FROM HIS POSITION.
Source text for Eikon: ID:nWkrc7H568
Further company coverage: ISOFOL.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical reports no Q2 revenue, net loss widens
Brief: Isofol Medical Q2 Net Income SEK -15.729 Million
Brief: Isofol Medical Adds Clinical Trial Sites To Phase Ib/Ii Arfolitixorin Study In Colorectal Cancer
Sweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million